Last updated: 2026-09-09 04:29:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Biofrontera Inc. (BFRI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1,56, with a market capitalization of $23,91M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,55 to $1,72. This page covers its latest market performance, valuation, price trends and company information.
$23,91M | |
$1,64 | |
$292,60 | |
$0,54 | |
$1,61 | |
823,66K | |
438,63K | |
-- | |
$1,72 | |
$0,55 | |
-- | |
-- |
Biofrontera Inc. (BFRI) last closed at $1,61 as of 2026-09-08 23:31:00, unchanged from the previous close of $1,61.
During the latest regular trading session, BFRI traded between $0,54 and $292,60, with a volume of 823,66K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Biofrontera Inc. (BFRI) moved from $1,49 to $1,56, representing a gain of 4,36% ($0,06).
The stock traded between $1,48 and $1,72 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 599,24 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 86,0%
BFRI is currently trading at $1,56, placing it 86,0% of the way from its 52-week low of $0,55 to its 52-week high of $1,72. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 94 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Biofrontera Inc. (BFRI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.